Evidence map›Paper›PMID 37550187›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research].

W Xu, S H Yi, R Feng, X Wang, J Jin, J Q Mi, K Y Ding, W Yang, T Niu, S Y Wang and 18 more

Open access · greenAbstract readMulticenter StudyEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 1 country.

W XuDepartment of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
S H YiState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
R FengNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
X WangShandong Provincial Hospital, Jinan 250021, China.
J JinThe First Affiliated Hospital of Medical College of Zhejiang University, Hangzhou 310003, China.
J Q MiRuijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai 200025, China.
K Y DingAnhui Province Cancer Hospital, Hefei 230031, China.
W YangShengjing Hospital Affiliated to China Medical University, Shenyang 117004, China.
T NiuWest China Hospital of Sichuan University, Chengdu 610044, China.
S Y WangUnion Hospital Affiliated to Fujian Medical University, Fuzhou 350001, China.
K S ZhouHenan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University), Zhengzhou 450003, China.
H L PengXiangya Second Hospital of Central South University, Changsha 410008, China.
L HuangTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
L H LiuThe Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital), Shijiazhuang 050011, China.
J MaHarbin Institute of hematological oncology, Harbin 150001, China.
J LuoThe First Affiliated Hospital of Guangxi Medical University, Nanchang 530021, China.
L P SuShanxi Cancer Hospital, Taiyuan 030013, China.
O BaiThe first hospital of Jilin University, Changchun 130061, China.
L LiuThe First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
F LiThe First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
P C HeThe First Affiliated Hospital of Xi' an Jiaotong University, Xi' an 710061, China.
Y ZengThe First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
D GaoAffiliated Hospital of Inner Mongolia Medical University, Hohhot 750306, China.
M JiangThe First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.
J S WangAffiliated hospital of Guizhou Medical University, Guiyang 550004, China.
H X YaoHainan Provincial People's Hospital, Haikou 570311, China.
L G QiuState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
J Y LiDepartment of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNChongqing Medical University · CNFirst Affiliated Hospital of Nanchang University · CNHainan Provincial Hospital of Traditional Chinese Medicine · CNJiangsu Province Hospital · CNKunming Medical University · CNNanfang Hospital · CNNanjing Medical University · CNShandong Provincial Hospital · CNShanxi Provincial Cancer Hospital · CNTongji Hospital · CNWest China Hospital of Sichuan University · CNXinjiang Medical University · CN

Funding

Beijing Bethune Charitable Foundation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, B-CellAgedFemaleHumansImmunoglobulin Heavy ChainsImmunohistochemistryMaleMiddle AgedPrognosisImmunoglobulin Heavy ChainsChronic lymphocytic leukemiaDiagnosisSurvey researchTherapeutic

Identifiers

PMID37550187
PMCPMC10440613
OpenAlexW4385680788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.